drugset / Trial / NCT03311269

A Study Evaluating ClariVein With a Sclerosing Agent for the Treatment of Venous Insufficiency

NCT03311269 ↗

Phase 2 Terminated 19 enrolled Vascular Insights, LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

VICARES is a prospective randomized, controlled, multi-center, double blind study treating venous insufficiency associated with incompetent saphenous veins with 1% and 3% Sodium Tetradecyl Sulfate (STS) solution utilizing the ClariVein system.

Timeline

Start
2017-09-22
Primary completion
2018-05-15
Completion
2020-03-27

Outcome

Outcome not reported

Stopped: “Study was terminated for administrative reasons”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sodium Tetradecyl Sulfate Unknown 1 % —
Comparator Sodium Tetradecyl Sulfate Unknown 3 % —

Indications